vs
奎斯特诊断（IMDX）与TRINITY BIOTECH PLC（TRIB）财务数据对比。点击上方公司名可切换其他公司
TRINITY BIOTECH PLC的季度营收约是奎斯特诊断的26.8倍（$30.5M vs $1.1M）。TRINITY BIOTECH PLC净利率更高（-33.0% vs -2015.4%，领先1982.4%）。TRINITY BIOTECH PLC自由现金流更多（$-4.1M vs $-7.0M）
奎斯特诊断公司是一家美国临床检验企业，跻身财富500强，业务覆盖美国本土，以及波多黎各、墨西哥、巴西等地区，同时与全球多家医院和诊所保持合作关系，是行业内颇具影响力的医疗诊断服务提供商。
Trinity Biotech PLC是一家全球体外诊断企业，研发、生产和销售适用于临床实验室与床旁检测场景的诊断试剂盒及配套系统，产品线覆盖糖尿病管理、传染病、心脏健康、自身免疫疾病等领域，主要市场包括北美、欧洲及全球新兴经济体。
IMDX vs TRIB — 直观对比
营收规模更大
TRIB
是对方的26.8倍
$1.1M
净利率更高
TRIB
高出1982.4%
-2015.4%
自由现金流更多
TRIB
多$3.0M
$-7.0M
损益表 — Q4 2025 vs Q2 2024
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $30.5M |
| 净利润 | $-23.0M | $-10.1M |
| 毛利率 | 42.5% | 36.8% |
| 营业利润率 | -2057.5% | -23.2% |
| 净利率 | -2015.4% | -33.0% |
| 营收同比 | -23.4% | — |
| 净利润同比 | 31.5% | — |
| 每股收益（稀释后） | $-0.75 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMDXTRIB
| Q4 25 | $1.1M | — | ||
| Q3 25 | $260.0K | — | ||
| Q2 25 | $518.0K | — | ||
| Q1 25 | $2.1M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $115.0K | — | ||
| Q2 24 | $104.0K | $30.5M | ||
| Q1 24 | $176.0K | — |
净利润IMDXTRIB
| Q4 25 | $-23.0M | — | ||
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $-9.7M | — | ||
| Q1 25 | $-6.7M | — | ||
| Q4 24 | $-33.5M | — | ||
| Q3 24 | $-13.5M | — | ||
| Q2 24 | $-4.5M | $-10.1M | ||
| Q1 24 | $-9.1M | — |
毛利率IMDXTRIB
| Q4 25 | 42.5% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 67.6% | — | ||
| Q1 25 | 62.0% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 43.5% | — | ||
| Q2 24 | 48.1% | 36.8% | ||
| Q1 24 | 25.6% | — |
营业利润率IMDXTRIB
| Q4 25 | -2057.5% | — | ||
| Q3 25 | -4249.2% | — | ||
| Q2 25 | -1900.0% | — | ||
| Q1 25 | -318.0% | — | ||
| Q4 24 | -2262.9% | — | ||
| Q3 24 | -11752.2% | — | ||
| Q2 24 | -4453.8% | -23.2% | ||
| Q1 24 | -5265.3% | — |
净利率IMDXTRIB
| Q4 25 | -2015.4% | — | ||
| Q3 25 | -4174.6% | — | ||
| Q2 25 | -1880.7% | — | ||
| Q1 25 | -312.0% | — | ||
| Q4 24 | -2255.1% | — | ||
| Q3 24 | -11733.0% | — | ||
| Q2 24 | -4355.8% | -33.0% | ||
| Q1 24 | -5186.9% | — |
每股收益（稀释后）IMDXTRIB
| Q4 25 | $-0.75 | — | ||
| Q3 25 | $-0.34 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.26 | — | ||
| Q4 24 | $-2.19 | — | ||
| Q3 24 | $-0.98 | — | ||
| Q2 24 | $-0.36 | — | ||
| Q1 24 | $-1.13 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | $5.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-31.5M | $-29.4M |
| 总资产 | $25.8M | $94.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMDXTRIB
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | — | ||
| Q2 25 | $24.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | $5.3M | ||
| Q1 24 | $5.6M | — |
股东权益IMDXTRIB
| Q4 25 | $-31.5M | — | ||
| Q3 25 | $-9.2M | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $-12.3M | — | ||
| Q3 24 | $9.7M | — | ||
| Q2 24 | $22.7M | $-29.4M | ||
| Q1 24 | $11.6M | — |
总资产IMDXTRIB
| Q4 25 | $25.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $50.5M | — | ||
| Q1 25 | $60.4M | — | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $70.2M | — | ||
| Q2 24 | $74.7M | $94.4M | ||
| Q1 24 | $71.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.5M | $-3.9M |
| 自由现金流经营现金流 - 资本支出 | $-7.0M | $-4.1M |
| 自由现金流率自由现金流/营收 | -616.7% | -13.3% |
| 资本支出强度资本支出/营收 | 129.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-25.4M | $-4.1M |
8季度趋势，按日历期对齐
经营现金流IMDXTRIB
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $-6.3M | — | ||
| Q1 25 | $-5.9M | — | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-5.5M | — | ||
| Q2 24 | $-6.0M | $-3.9M | ||
| Q1 24 | $-3.8M | — |
自由现金流IMDXTRIB
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | — | ||
| Q2 24 | $-6.2M | $-4.1M | ||
| Q1 24 | $-3.9M | — |
自由现金流率IMDXTRIB
| Q4 25 | -616.7% | — | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | — | ||
| Q2 24 | -5931.7% | -13.3% | ||
| Q1 24 | -2189.8% | — |
资本支出强度IMDXTRIB
| Q4 25 | 129.9% | — | ||
| Q3 25 | 403.8% | — | ||
| Q2 25 | 67.4% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | — | ||
| Q2 24 | 183.7% | 0.5% | ||
| Q1 24 | 13.6% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
